From early prophylaxis to delayed treatment: Establishing the plutonium decorporation activity window of hydroxypyridinonate chelating agents

Yazar: An, Dahlia D., Kullgren, Birgitta, Jarvis, Erin E., Abergel, Rebecca J.
Yayımlandı Chem Biol Interact (2016)

Dose-Dependent Efficacy and Safety Toxicology of Hydroxypyridinonate Actinide Decorporation Agents in Rodents: Towards a Safe and EffectiveHuman Dosing Regimen

Yazar: Bunin, Deborah I., Chang, Polly Y., Doppalapudi, Rupa S., Riccio, Edward S., An, Dahlia, Jarvis, Erin E., Kullgren, Birgitta, Abergel, Rebecca J.
Baskı/Yayın Bilgisi 2013

Efficient discrimination of transplutonium actinides by in vivo models

Yazar: Pallares, Roger M., An, Dahlia D., Deblonde, Gauthier J.-P., Kullgren, Birgitta, Gauny, Stacey S., Jarvis, Erin E., Abergel, Rebecca J.
Yayımlandı Chem Sci (2021)

Biomimetic Actinide Chelators: An Update on the Preclinical Development of the Orally Active Hydroxypyridonate Decorporation Agents 3,4,3-LI(1,2-HOPO) and 5-LIO(Me-3,2-HOPO)

Yazar: Abergel, Rebecca J., Durbin, Patricia W., Kullgren, Birgitta, Ebbe, Shirley N., Xu, Jide, Chang, Polly Y., Bunin, Deborah I., Blakely, Eleanor A., Bjornstad, Kathleen A., Rosen, Chris J., Shuh, David K., Raymond, Kenneth N.
Baskı/Yayın Bilgisi 2010